Process for producing kiss-1 peptide
CA 2394404 A1 · Owner: Takeda Chemical Industries, Ltd. · Inventors: Nishimura, Osamu; Yamada, Takao; Suenaga, Masato
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
KiSS-1 peptide or its salt can be industrially produced on a mass scale by subjecting a fused protein or peptide, wherein KiSS-1 peptide is ligated to the N-end of a protein or a peptide having cysteine at the N-end to the , reaction of cleaving the peptide bond in the amino acid side of the cysteine residue.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 14, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.